Several of our results support the idea of a possible pathogenic role of RAB12 mutations in MD and probably also other dystonias including increased GTPase activities, altered lysosomal distribution, reduced levels of soluble TFRC in patients, and the finding that RAB12 mutations were found with a higher frequency in dystonia patients than in controls. This evidence concerns the gene RAB12 and Dystonia.